1
|
Urbonavičius A, Krikštolaitytė S, Bieliauskas A, Martynaitis V, Solovjova J, Žukauskaitė A, Arbačiauskienė E, Šačkus A. Synthesis and Characterization of New Pyrano[2,3- c]pyrazole Derivatives as 3-Hydroxyflavone Analogues. Molecules 2023; 28:6599. [PMID: 37764375 PMCID: PMC10537540 DOI: 10.3390/molecules28186599] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/12/2023] [Revised: 09/01/2023] [Accepted: 09/09/2023] [Indexed: 09/29/2023] Open
Abstract
In this paper, an efficient synthetic route from pyrazole-chalcones to novel 6-aryl-5-hydroxy-2-phenylpyrano[2,3-c]pyrazol-4(2H)-ones as 3-hydroxyflavone analogues is described. The methylation of 5-hydroxy-2,6-phenylpyrano[2,3-c]pyrazol-4(2H)-one with methyl iodide in the presence of a base yielded a compound containing a 5-methoxy group, while the analogous reaction of 5-hydroxy-2-phenyl-6-(pyridin-4-yl)pyrano[2,3-c]pyrazol-4(2H)-one led to the zwitterionic 6-(N-methylpyridinium)pyrano[2,3-c]pyrazol derivative. The treatment of 5-hydroxy-2,6-phenylpyrano[2,3-c]pyrazol-4(2H)-one with triflic anhydride afforded a 5-trifloylsubstituted compound, which was further used in carbon-carbon bond forming Pd-catalyzed coupling reactions to yield 5-(hetero)aryl- and 5-carbo-functionalized pyrano[2,3-c]pyrazoles. The excited-state intramolecular proton transfer (ESIPT) reaction of 5-hydroxypyrano[2,3-c]pyrazoles from the 5-hydroxy moiety to the carbonyl group in polar protic, polar aprotic, and nonpolar solvents was observed, resulting in well-resolved two-band fluorescence. The structures of the novel heterocyclic compounds were confirmed by 1H-, 13C-, 15N-, and 19F-NMR spectroscopy, HRMS, and single-crystal X-ray diffraction data.
Collapse
Affiliation(s)
- Arminas Urbonavičius
- Department of Organic Chemistry, Kaunas University of Technology, Radvilėnų pl. 19, LT-50254 Kaunas, Lithuania; (A.U.); (S.K.); (V.M.); (J.S.); (A.Ž.)
- Institute of Synthetic Chemistry, Kaunas University of Technology, K. Baršausko g. 59, LT-51423 Kaunas, Lithuania;
| | - Sonata Krikštolaitytė
- Department of Organic Chemistry, Kaunas University of Technology, Radvilėnų pl. 19, LT-50254 Kaunas, Lithuania; (A.U.); (S.K.); (V.M.); (J.S.); (A.Ž.)
| | - Aurimas Bieliauskas
- Institute of Synthetic Chemistry, Kaunas University of Technology, K. Baršausko g. 59, LT-51423 Kaunas, Lithuania;
| | - Vytas Martynaitis
- Department of Organic Chemistry, Kaunas University of Technology, Radvilėnų pl. 19, LT-50254 Kaunas, Lithuania; (A.U.); (S.K.); (V.M.); (J.S.); (A.Ž.)
| | - Joana Solovjova
- Department of Organic Chemistry, Kaunas University of Technology, Radvilėnų pl. 19, LT-50254 Kaunas, Lithuania; (A.U.); (S.K.); (V.M.); (J.S.); (A.Ž.)
| | - Asta Žukauskaitė
- Department of Organic Chemistry, Kaunas University of Technology, Radvilėnų pl. 19, LT-50254 Kaunas, Lithuania; (A.U.); (S.K.); (V.M.); (J.S.); (A.Ž.)
- Department of Chemical Biology, Palacký University, Šlechtitelů 27, CZ-78371 Olomouc, Czech Republic
| | - Eglė Arbačiauskienė
- Department of Organic Chemistry, Kaunas University of Technology, Radvilėnų pl. 19, LT-50254 Kaunas, Lithuania; (A.U.); (S.K.); (V.M.); (J.S.); (A.Ž.)
| | - Algirdas Šačkus
- Institute of Synthetic Chemistry, Kaunas University of Technology, K. Baršausko g. 59, LT-51423 Kaunas, Lithuania;
| |
Collapse
|
2
|
de Araújo RSA, Carmo JDODS, de Omena Silva SL, Costa da Silva CRA, Souza TPM, de Mélo NB, Bourguignon JJ, Schmitt M, de Aquino TM, Rodarte RS, de Moura RO, Barbosa Filho JM, Barreto E, Mendonça-Junior FJB. Coumarin Derivatives Exert Anti-Lung Cancer Activity by Inhibition of Epithelial–Mesenchymal Transition and Migration in A549 Cells. Pharmaceuticals (Basel) 2022; 15:ph15010104. [PMID: 35056161 PMCID: PMC8782015 DOI: 10.3390/ph15010104] [Citation(s) in RCA: 11] [Impact Index Per Article: 5.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/20/2021] [Revised: 01/04/2022] [Accepted: 01/06/2022] [Indexed: 01/27/2023] Open
Abstract
A series of coumarin derivatives and isosteres were synthesized from the reaction of triflic intermediates with phenylboronic acids, terminal alkynes, and organozinc compounds through palladium-catalyzed cross-coupling reactions. The in vitro cytotoxic effect of the compounds was evaluated against two non-small cell lung carcinoma (NSCLC) cell lines (A-549 and H2170) and a normal cell line (NIH-3T3) using cisplatin as a reference drug. Additionally, the effects of the most promising coumarin derivative (9f) in reversing the epithelial-to-mesenchymal transition (EMT) in IL-1β-stimulated A549 cells and in inhibiting the EMT-associated migratory ability in A549 cells were also evaluated. 9f had the greatest cytotoxic effect (CC50 = 7.1 ± 0.8 and 3.3 ± 0.5 μM, respectively against A549 and H2170 cells) and CC50 value of 25.8 µM for NIH-3T3 cells. 9f inhibited the IL-1β-induced EMT in epithelial cells by inhibiting the F-actin reorganization, attenuating changes in the actin cytoskeleton reorganization, and downregulating vimentin in A549 cells stimulated by IL-1β. Treatment of A549 cells with 9f at 7 µM for 24 h significantly reduced the migration of IL-1β-stimulated cells, which is a phenomenon confirmed by qualitative assessment of the wound closure. Taken together, our findings suggest that coumarin derivatives, especially compound 9f, may become a promising candidate for lung cancer therapy, especially in lung cancer promoted by NSCLC cell lines.
Collapse
Affiliation(s)
- Rodrigo Santos Aquino de Araújo
- Laboratory of Synthesis and Drug Delivery, Department of Biological Sciences, State University of Paraiba, João Pessoa 58429-500, PB, Brazil; (R.S.A.d.A.); (N.B.d.M.); (R.O.d.M.)
- Laboratoire d’Innovation Thérapeutique, UMR 7200, Labex Medalis, CNRS, Université de Strasbourg, Faculté de Pharmacie, 74 route du Rhin, BP 60024, 67401 Illkirch, France; (J.-J.B.); (M.S.)
| | - Julianderson de Oliveira dos Santos Carmo
- Institute of Biological and Health Sciences, Federal University of Alagoas, Maceio 57072-900, AL, Brazil; (J.d.O.d.S.C.); (S.L.d.O.S.); (C.R.A.C.d.S.); (T.P.M.S.); (R.S.R.)
| | - Simone Lara de Omena Silva
- Institute of Biological and Health Sciences, Federal University of Alagoas, Maceio 57072-900, AL, Brazil; (J.d.O.d.S.C.); (S.L.d.O.S.); (C.R.A.C.d.S.); (T.P.M.S.); (R.S.R.)
| | - Camila Radelley Azevedo Costa da Silva
- Institute of Biological and Health Sciences, Federal University of Alagoas, Maceio 57072-900, AL, Brazil; (J.d.O.d.S.C.); (S.L.d.O.S.); (C.R.A.C.d.S.); (T.P.M.S.); (R.S.R.)
| | - Tayhana Priscila Medeiros Souza
- Institute of Biological and Health Sciences, Federal University of Alagoas, Maceio 57072-900, AL, Brazil; (J.d.O.d.S.C.); (S.L.d.O.S.); (C.R.A.C.d.S.); (T.P.M.S.); (R.S.R.)
| | - Natália Barbosa de Mélo
- Laboratory of Synthesis and Drug Delivery, Department of Biological Sciences, State University of Paraiba, João Pessoa 58429-500, PB, Brazil; (R.S.A.d.A.); (N.B.d.M.); (R.O.d.M.)
| | - Jean-Jacques Bourguignon
- Laboratoire d’Innovation Thérapeutique, UMR 7200, Labex Medalis, CNRS, Université de Strasbourg, Faculté de Pharmacie, 74 route du Rhin, BP 60024, 67401 Illkirch, France; (J.-J.B.); (M.S.)
| | - Martine Schmitt
- Laboratoire d’Innovation Thérapeutique, UMR 7200, Labex Medalis, CNRS, Université de Strasbourg, Faculté de Pharmacie, 74 route du Rhin, BP 60024, 67401 Illkirch, France; (J.-J.B.); (M.S.)
| | - Thiago Mendonça de Aquino
- Research Group on Therapeutic Strategies—GPET, Institute of Chemistry and Biotechnology, Federal University of Alagoas, Maceio 57072-900, AL, Brazil;
| | - Renato Santos Rodarte
- Institute of Biological and Health Sciences, Federal University of Alagoas, Maceio 57072-900, AL, Brazil; (J.d.O.d.S.C.); (S.L.d.O.S.); (C.R.A.C.d.S.); (T.P.M.S.); (R.S.R.)
| | - Ricardo Olímpio de Moura
- Laboratory of Synthesis and Drug Delivery, Department of Biological Sciences, State University of Paraiba, João Pessoa 58429-500, PB, Brazil; (R.S.A.d.A.); (N.B.d.M.); (R.O.d.M.)
| | - José Maria Barbosa Filho
- Post-Graduate Program in Natural and Synthetic Bioactive Products, Federal University of Paraíba, João Pessoa 58051-900, PB, Brazil;
| | - Emiliano Barreto
- Institute of Biological and Health Sciences, Federal University of Alagoas, Maceio 57072-900, AL, Brazil; (J.d.O.d.S.C.); (S.L.d.O.S.); (C.R.A.C.d.S.); (T.P.M.S.); (R.S.R.)
- Correspondence: (E.B.); (F.J.B.M.-J.)
| | - Francisco Jaime Bezerra Mendonça-Junior
- Laboratory of Synthesis and Drug Delivery, Department of Biological Sciences, State University of Paraiba, João Pessoa 58429-500, PB, Brazil; (R.S.A.d.A.); (N.B.d.M.); (R.O.d.M.)
- Post-Graduate Program in Natural and Synthetic Bioactive Products, Federal University of Paraíba, João Pessoa 58051-900, PB, Brazil;
- Correspondence: (E.B.); (F.J.B.M.-J.)
| |
Collapse
|
3
|
Kovalevsky RA, Kucherenko AS, Korlyukov AA, Zlotin SG. Asymmetric Conjugate Addition of 3‐Hydroxychromen‐4‐Ones to Electron‐Deficient Olefins Catalyzed by Recyclable C
2
‐Symmetric Squaramide. Adv Synth Catal 2021. [DOI: 10.1002/adsc.202101019] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/07/2023]
Affiliation(s)
- Ruslan A. Kovalevsky
- N.D. Zelinsky Institute of Organic Chemistry Russian Academy of Sciences 47 Leninsky Prospect 119991 Moscow Russian Federation
- M.V. Lomonosov Moscow State University Department of Chemistry Leninskie gory 1–3 119234 Moscow Russian Federation
| | - Alexander S. Kucherenko
- N.D. Zelinsky Institute of Organic Chemistry Russian Academy of Sciences 47 Leninsky Prospect 119991 Moscow Russian Federation
| | - Alexander A. Korlyukov
- A.N. Nesmeyanov Institute of Organoelement Compounds Russian Academy of Sciences 119991 Moscow Russian Federation
| | - Sergei G. Zlotin
- N.D. Zelinsky Institute of Organic Chemistry Russian Academy of Sciences 47 Leninsky Prospect 119991 Moscow Russian Federation
| |
Collapse
|
4
|
Chang Y, Liu L, Peng W, Lin L, Chan Y, Tsai F. Stille coupling for the synthesis of isoflavones by a reusable palladium catalyst in water. J CHIN CHEM SOC-TAIP 2021. [DOI: 10.1002/jccs.202000478] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
Affiliation(s)
- Ya‐Ting Chang
- Institute of Organic and Polymeric Materials National Taipei University of Technology Taipei Taiwan
| | - Ling‐Jun Liu
- Institute of Organic and Polymeric Materials National Taipei University of Technology Taipei Taiwan
| | - Wen‐Sheng Peng
- Institute of Organic and Polymeric Materials National Taipei University of Technology Taipei Taiwan
| | - Lin‐Ting Lin
- Department of Chemistry National Taiwan University Taipei Taiwan
| | - Yi‐Tsu Chan
- Department of Chemistry National Taiwan University Taipei Taiwan
| | - Fu‐Yu Tsai
- Institute of Organic and Polymeric Materials National Taipei University of Technology Taipei Taiwan
| |
Collapse
|
5
|
Tripathi G, Singh AK, Kumar A. Arylpyrazoles: Heterocyclic Scaffold of Immense Therapeutic Application. CURR ORG CHEM 2020. [DOI: 10.2174/1570179417999200628035645] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/08/2023]
Abstract
Among the major class of heterocycles, the N-heterocycles, such as pyrazoles,
are scaffolds of vast medicinal values. Various drugs and other biologically active molecules
are known to contain these N-heterocycles as core motifs. Specifically, arylpyrazoles
have exhibited a diverse range of biological activities, including anti-inflammatory, anticancerous,
antimicrobial and various others. For instance, arylpyrazoles are present as
core moieties in various insecticides, fungicides and drugs such as Celebrex and Trocoxil.
The present review will be highlighting the significant therapeutic importance of pyrazole
derivatives developed in the last few years.
Collapse
Affiliation(s)
- Garima Tripathi
- Department of Chemistry, T. N. B. College, Tilka Manjhi Bhagalpur University, Bhagalpur, Bihar, India
| | - Anil Kumar Singh
- Department of Chemistry, School of Physical Sciences, Mahatma Gandhi Central University, Bihar, India
| | - Abhijeet Kumar
- Department of Chemistry, School of Physical Sciences, Mahatma Gandhi Central University, Bihar, India
| |
Collapse
|
6
|
Rane JS, Pandey P, Chatterjee A, Khan R, Kumar A, Prakash A, Ray S. Targeting virus-host interaction by novel pyrimidine derivative: an in silico approach towards discovery of potential drug against COVID-19. J Biomol Struct Dyn 2020; 39:5768-5778. [PMID: 32684109 PMCID: PMC7441775 DOI: 10.1080/07391102.2020.1794969] [Citation(s) in RCA: 25] [Impact Index Per Article: 6.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/09/2023]
Abstract
The entire human population over the globe is currently facing appalling conditions due
to the spread of infection from coronavirus disease-2019 (COVID-19). The spike
glycoprotein of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) present on
the surface of the virion mediates the virus entry into the host cells and therefore is
targeted by several scientific groups as a novel drug target site. The spike glycoprotein
binds to the human angiotensin-converting enzyme-2 (hACE2) cell surface receptor
abundantly expressed in lung tissues, and this binding phenomenon is a primary determinant
of cell tropism and pathogenesis. The binding and internalization of the virus is the
primary and most crucial step in the process of infection, and therefore the molecules
targeting the inhibition of this process certainly hold a significant therapeutic value.
Thus, we systematically applied the computational techniques to identify the plausible
inhibitor from a chosen set of well characterized diaryl pyrimidine analogues which may
disrupt interfacial interaction of spike glycoprotein (S) at the surface of hACE2. Using
molecular docking, molecular dynamics (MD) simulation and binding free energy calculation,
we have identified AP-NP (2-(2-amino-5-(naphthalen-2-yl)pyrimidin-4-yl)phenol),
AP-3-OMe-Ph (2-(2-amino-5-(3-methoxyphenyl)pyrimidin-4-yl)phenol) and AP-4-Me-Ph
(2-(2-amino-5-(p-tolyl) pyrimidin-4-yl)phenol) from a group of diaryl pyrimidine
derivatives which appears to bind at the interface of the hACE2-S complex with low binding
free energy. Thus, pyrimidine derivative AP-NP may be explored as an effective inhibitor
for hACE2-S complex. Furthermore, in vitro and in vivo studies will strengthen the use of these inhibitors as
suitable drug candidates against SARS-COV-2. Communicated by Ramaswamy H. Sarma
Collapse
Affiliation(s)
- Jitendra Subhash Rane
- Department of Biosciences & Bioengineering, Indian Institute of Technology Bombay, Mumbai, India
| | - Preeti Pandey
- Department of Chemistry & Biochemistry, University of Oklahoma, Norman, OK, USA
| | - Aroni Chatterjee
- Indian Council of Medical Research (ICMR)-Virus Research Laboratory, NICED, Kolkata, India
| | - Rajni Khan
- Motihari College of Engineering, Motihari, India
| | - Abhijeet Kumar
- Department of Chemistry, Mahatma Gandhi Central University, Motihari, India
| | - Amresh Prakash
- Amity Institute of Integrative Sciences and Health, Amity University Haryana, Gurgaon, India
| | - Shashikant Ray
- Department of Biotechnology, Mahatma Gandhi Central University, Motihari, India
| |
Collapse
|